Showing results 1 to 2 of 2
Issue Date | Title | Journal Title |
---|---|---|
2015 | Phase II clinical and exploratory biomarker study of dacomitinib in recurrent and/or metastatic esophageal squamous cell carcinoma | ONCOTARGET |
2016 | PIK3CA amplification is associated with poor prognosis among patients with curatively resected esophageal squamous cell carcinoma. | ONCOTARGET |